Two Sigma Investments
COCP icon

Two Sigma Investments’s Cocrystal Pharma COCP Stock Holding History

Two Sigma Investments’s Portfolio COCP Stock Details COCP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$184K Buy
+175,379
New +$216K ﹤0.01% 4808

Other funds holding COCP

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

Two Sigma Investments's COCP Position: Q2 2026 in Review

Two Sigma Investments opened a new position in Cocrystal Pharma (COCP) in Q2 2026: 175,379 shares worth $184K. The stake represents ﹤0.01% of the portfolio and ranks #4808 among its holdings.

22 funds tracked by Wall St. Rank hold COCP as of Q2 2026.

  • Two Sigma Investments held 175,379 shares of Cocrystal Pharma worth $184K as of Q2 2026.
  • Cocrystal Pharma was a new Two Sigma Investments position in Q2 2026.
  • Cocrystal Pharma made up ﹤0.01% of Two Sigma Investments's portfolio in Q2 2026, its #4808 holding.
  • 22 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.